Pharmaceuticals

Global Oncology Biosimilars Market Size, Forecasts, And Opportunities

December 8, 2021 by The Business Research Company

Learn about the global oncology biosimilars market through The Business Research Company, which provides information on oncology biosimilars market size, oncology biosimilars market drivers and restraints, oncology biosimilars market players, the COVID-19 impact on the oncology biosimilars market, and more.

Our annual holiday sale is here! Get your discounted market research reports today.

The global oncology biosimilars market is expected to grow from $2.88 billion in 2020 to $3.1 billion in 2021 at a compound annual growth rate (CAGR) of 7.6%. The growth is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The oncology biosimilars market is expected to reach $8.39 billion in 2025 at a CAGR of 28%.

The expiration of patent of biologics used for the treatment of cancer is expected to drive innovation in oncology biosimilars manufacturing, thus driving the market during the forecast period.

Request A Sample For The Global Oncology Biosimilars Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2821&type=smph

The oncology biosimilars market consists of sales of medicine and drug related products for cancer treatment. Biosimilars are pharmaceuticals which are manufactured using cell lines and are exclusive to the manufacturer. The manufacturing of these cell line processes is a complex and time-consuming process.

Global oncology biosimilars market segments include:

By Drug Type: Monoclonal Antibody, Immunomodulators, Hematopoietic Agents, Granulocyte Colony-Stimulating Factor (G-CSF)

By Cancer Type: Breast Cancer, Colorectal Cancer, Blood Cancer, Neutropenia Cancer, Non-Small Cell Lung Cancer, Others

By Distribution Type: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy

By Geography: The market is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa.

The pharmaceutical companies are increasingly investing in research and development to produce new oncology biosimilars. The companies are exploiting growth potential of rising biosimilar market by investing in their research and development (R&D) processes to support the research and production process of new biosimilars.

TBRC’s oncology biosimilars market report covers:

Major Market Players: Biocoin, Celltrion Inc., Dr. Reddy’s Laboratories Ltd., Intas Pharmaceuticals Ltd., STADA Arzneimittel AG, Pfizer Inc., Apotex Inc., Teva Pharmaceutical Industries Ltd., Sandoz International GmbH and BIOCAD.

Regions: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.

Countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

Time Series: Five years historic (2015-20) and ten years forecast (2021-2025-2030)

The Oncology Biosimilars Global Market Report 2021: COVID-19 Growth and Change to 2030 is one of a series of new reports from The Business Research Company that provides oncology biosimilars market overviews, analyzes and forecasts market size, share, oncology biosimilars market players, oncology biosimilars market segments and geographies, leading competitor revenues, profiles and market shares.

TBRC’s oncology biosimilars market report identifies top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.

Here Is A List Of Similar Reports From The Business Research Company:

Interested To Know More About The Business Research Company?

The Business Research Company has published over 1000 industry reports, covering over 2500 market segments and 60 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. The reports are updated with a detailed analysis of the impact of COVID-19 on various markets.

The Business Research Company

Europe: +44 207 1930 708

Asia: +91 8897263534

Americas: +1 315 623 0293

Email: info@tbrc.info

Check out our Blog: https://blog.tbrc.info/

Check out our Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model